Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1141-1160 of 1,550 trials

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus irinotecan in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Jan 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

NCT00025675

RATIONALE: Biological therapies such as gefitinib may interfere with the growth of tumor cells and slow the growth of CNS tumors. PURPOSE: Phase II trial to study the effectiveness of gefitinib in treating patients who have recurrent or progressive CNS tumors.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins105 participantsStarted Oct 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +9 more locations

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Rheumatoid Arthritis Trials in Other Cities

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

A Study in Participants With Rheumatoid Arthritis

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY

Cornea Preservation Time Study

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

A Rheumatoid Arthritis Study in Participants

Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men

Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Telescope Exchange Study

Phase 1 and 2 Study of PX-866 and Cetuximab

OLIF25™ /OLIF51™ Study

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

PF-00489791 For The Treatment Of Raynaud's

Other Conditions in Los Angeles